Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AORTNASDAQ:IRMDNASDAQ:MDXGNASDAQ:OFIX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAORTArtivion$31.17-0.1%$28.16$21.97▼$32.33$1.33B1.61337,498 shs536,060 shsIRMDiRadimed$59.79-1.7%$55.76$42.34▼$63.29$773.59M0.9243,701 shs71,372 shsMDXGMiMedx Group$6.11+2.9%$6.54$5.47▼$10.14$877.35M1.83673,637 shs753,961 shsOFIXOrthofix Medical$11.15+0.5%$11.82$10.24▼$20.73$434.52M0.8287,188 shs361,458 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAORTArtivion0.00%+2.87%+5.37%+26.53%+21.52%IRMDiRadimed0.00%+4.46%+4.72%+15.93%+38.46%MDXGMiMedx Group0.00%+2.24%-8.19%-21.84%-14.29%OFIXOrthofix Medical0.00%+7.25%-1.68%-32.00%-16.37%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAORTArtivion2.3786 of 5 stars1.64.00.00.02.72.51.9IRMDiRadimed4.6633 of 5 stars2.52.02.54.42.73.31.9MDXGMiMedx Group3.7968 of 5 stars3.53.00.00.02.53.31.9OFIXOrthofix Medical3.1967 of 5 stars3.52.00.00.02.13.31.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAORTArtivion 3.14Buy$32.002.66% UpsideIRMDiRadimed 3.00Buy$72.0020.42% UpsideMDXGMiMedx Group 3.00Buy$12.50104.58% UpsideOFIXOrthofix Medical 3.00Buy$21.5092.83% UpsideCurrent Analyst Ratings BreakdownLatest MDXG, OFIX, AORT, and IRMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/23/2025OFIXOrthofix MedicalBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$16.006/17/2025AORTArtivionCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$35.006/6/2025OFIXOrthofix MedicalJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Perform ➝ Market Perform5/6/2025AORTArtivionCitizens JmpSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/6/2025AORTArtivionJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$33.00 ➝ $33.005/6/2025AORTArtivionNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$32.00 ➝ $32.00(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAORTArtivion$388.54M3.43$0.83 per share37.38$6.59 per share4.73IRMDiRadimed$73.24M10.38$1.56 per share38.45$6.85 per share8.73MDXGMiMedx Group$348.88M2.59$0.34 per share17.93$1.31 per share4.66OFIXOrthofix Medical$799.49M0.55N/AN/A$13.07 per share0.85Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAORTArtivion-$13.36M-$0.50N/A62.34N/A-5.49%3.63%1.34%8/6/2025 (Estimated)IRMDiRadimed$19.23M$1.5538.5729.90N/A26.33%23.28%20.59%7/30/2025 (Estimated)MDXGMiMedx Group$42.42M$0.2722.6319.09N/A11.40%22.70%16.77%7/30/2025 (Estimated)OFIXOrthofix Medical-$126M-$3.69N/AN/AN/A-17.78%-28.15%-16.51%8/5/2025 (Estimated)Latest MDXG, OFIX, AORT, and IRMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2025Q1 2025AORTArtivion$0.12$0.06-$0.06-$0.01$94.81 million$98.98 million4/30/2025Q1 2025MDXGMiMedx Group$0.06$0.06N/A$0.05$86.32 million$88.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAORTArtivionN/AN/AN/AN/AN/AIRMDiRadimed$0.681.14%N/A43.87%1 YearsMDXGMiMedx GroupN/AN/AN/AN/AN/AOFIXOrthofix MedicalN/AN/AN/AN/AN/ALatest MDXG, OFIX, AORT, and IRMD DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/5/2025IRMDiRadimedquarterly$0.171.3%5/20/20255/20/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAORTArtivion1.085.533.95IRMDiRadimedN/A8.877.62MDXGMiMedx Group0.094.704.13OFIXOrthofix Medical0.382.711.50Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAORTArtivion86.37%IRMDiRadimed92.34%MDXGMiMedx Group79.15%OFIXOrthofix Medical89.76%Insider OwnershipCompanyInsider OwnershipAORTArtivion8.10%IRMDiRadimed36.80%MDXGMiMedx Group1.70%OFIXOrthofix Medical1.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAORTArtivion1,60042.70 million39.24 millionOptionableIRMDiRadimed11012.72 million8.04 millionOptionableMDXGMiMedx Group870147.70 million145.19 millionOptionableOFIXOrthofix Medical1,61639.18 million38.67 millionOptionableMDXG, OFIX, AORT, and IRMD HeadlinesRecent News About These CompaniesOrthofix Medical Inc. (NASDAQ:OFIX) Given Consensus Rating of "Buy" by BrokeragesJune 28 at 5:03 AM | americanbankingnews.comOrthofix Medical (NASDAQ:OFIX) Cut to Sell at Wall Street ZenJune 27 at 12:09 AM | marketbeat.comQ2 Earnings Forecast for OFIX Issued By Barrington ResearchJune 27 at 2:21 AM | americanbankingnews.comWhat is Barrington Research's Forecast for OFIX Q2 Earnings?June 26, 2025 | marketbeat.comBarrington Research Upgrades Orthofix Medical (NASDAQ:OFIX) to Strong-BuyJune 25, 2025 | americanbankingnews.comBarrington Research Initiates Coverage of Orthofix Medical (OFIX) with Outperform RecommendationJune 24, 2025 | msn.comOrthofix Medical Inc. (NASDAQ:OFIX) Insider Aviva Mcpherron Sells 3,728 SharesJune 24, 2025 | insidertrades.comInsider Selling: Orthofix Medical Inc. (NASDAQ:OFIX) Insider Sells 3,728 Shares of StockJune 23, 2025 | marketbeat.comOrthofix Medical Inc. (NASDAQ:OFIX) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 23, 2025 | marketbeat.comBarrington Research Begins Coverage on Orthofix Medical (NASDAQ:OFIX)June 23, 2025 | marketbeat.comOrthofix Shareholders Meeting and Board ElectionsJune 20, 2025 | tipranks.comAssenagon Asset Management S.A. Has $1.18 Million Stock Position in Orthofix Medical Inc. (NASDAQ:OFIX)June 18, 2025 | marketbeat.comOrthofix Announces Global Commercial Launch of the TrueLok Elevate Transverse Bone Transport SystemJune 17, 2025 | finance.yahoo.comOrthofix Medical (NASDAQ:OFIX) shareholders have endured a 67% loss from investing in the stock five years agoJune 17, 2025 | finance.yahoo.comOrthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 43.4% in MayJune 16, 2025 | marketbeat.comWall Street Zen Upgrades Orthofix Medical (NASDAQ:OFIX) to "Hold"June 14, 2025 | marketbeat.comWall Street Zen Downgrades Orthofix Medical (NASDAQ:OFIX) to SellJune 6, 2025 | marketbeat.comOrthofix Medical's (OFIX) Market Perform Rating Reaffirmed at JMP SecuritiesJune 6, 2025 | marketbeat.comOrthofix Medical Inc. (NASDAQ:OFIX) Director Purchases $24,570.00 in StockJune 6, 2025 | insidertrades.comOrthofix Medical Inc. (NASDAQ:OFIX) Short Interest UpdateJune 5, 2025 | marketbeat.comOrthofix Reports Larger Than Expected Loss Per ShareJune 5, 2025 | ryortho.comRNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMDXG, OFIX, AORT, and IRMD Company DescriptionsArtivion NYSE:AORT$31.17 -0.02 (-0.06%) As of 03:58 PM EasternArtivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.iRadimed NASDAQ:IRMD$59.79 -1.05 (-1.73%) As of 04:00 PM EasternIRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.MiMedx Group NASDAQ:MDXG$6.11 +0.17 (+2.86%) As of 04:00 PM EasternMiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.Orthofix Medical NASDAQ:OFIX$11.15 +0.06 (+0.54%) As of 04:00 PM EasternOrthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
